In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1. 1In vivo inhibition of miR-125b-5p modulates monocyte trafficking through the CCR7 receptor and reduces atherosclerosis2025
2. 2In vivo inhibition of miR-125b modulates monocyte trafficking through the CCR7 receptor and attenuates atherosclerosis2024
3. 3microRNA-125b-1-3p mediates autophagy via the RRAGD/mTOR/ULK1 signaling pathway and mitigates atherosclerosis progression2024 · 5 citations
4. 4Upregulation of MicroRNA-125b Leads to the Resistance to Inflammatory Injury in Endothelial Progenitor Cells2020 · 3 citations
5. 5Expression Analysis of <i>miR-20a-5p</i>, <i>miR-124-3P, miR-125b-5p, Resistin</i>, <i>TLR4</i>, <i>CD36</i> and <i>TNF-α</i> relationship in blood mononuclear cells from patients with atherosclerosis.2025